Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.
Explore this paper's citation graph
Summary
A review of recent findings regarding the renoprotective effects of PPARgamma in Type 2 diabetes and the potential underlying mechanisms is discussed.
- Type
- dissertation
- Published
- 2009-01-01
- Cited by
- 55
- References
- 131
- Access
- Open access
- OpenAlex
- https://openalex.org/W19037881
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10813338
Keywords
Psychology, Philosophy, Humanities
References
- Renal epithelial cell hyperplasia and hypertrophy.
- Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-κB activation
- Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
- Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats.
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
- Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
- Adiponectin, an adipocyte-derived protein.
- Role of macrophages in the pathogenesis of diabetic nephropathy.
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
- Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.
- Amylin deposition in the kidney of patients with diabetic nephropathy.
- Salicylic Acid Reverses Phorbol 12-Myristate-13-Acetate (PMA)- and Tumor Necrosis Factor α (TNFα)-induced Insulin Receptor Substrate 1 (IRS1) Serine 307 Phosphorylation and Insulin Resistance in Human Embryonic Kidney 293 (HEK293) Cells*
- Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
- Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury
- Fibrillogenic amylin evokes the apoptosis of human mesangial cells.
- Cell cycle control in glomerular disease
- [Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy].
- The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
- Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective.
- Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study.
Cited by
- Phenotypic Characterization of the Pancreatic-Derived Factor (PANDER) Knockout Mouse on Pure C57BL/6 Background
- Podocyte repair and recovery in kidney disease
- Diabetic nephropathy: What does the future hold?
- Evaluation of the In vitro Anti-hyperglycemic Effect of Cinnamomum cassia Derived Phenolic Phytochemicals, via Carbohydrate Hydrolyzing Enzyme Inhibition
- The mechanisms linking adiposopathy to type 2 diabetes
- Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease.
- Diabetic nephropathy: diagnosis and treatment
- Hydrochloride pioglitazone decreases urinary monocyte chemoattractant protein-1 excretion in type 2 diabetics.
- C. elegans Genetic Networks Predict Roles for O-GlcNAc Cycling in Key Signaling Pathways
- Glitazones in chronic kidney disease: potential and concerns.
- Curcumin Inhibits Transforming Growth Factor-β1-Induced EMT via PPARγ Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes.
- Podocyte Biology for the Bedside
- Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
- Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
- FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.
- Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
- PPARγ Agonist Beyond Glucose Lowering Effect
- Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis
- Thiazolidinediones alter growth and epithelial cell integrity, independent of PPAR-γ and MAPK activation, in mouse M1 cortical collecting duct cells.
Related papers
No related papers recorded.